Blog Full Right Sidebar

Indian equity markets face policy risks from US tariffs and West Asia conflict. These issues impact metals and pharmaceutical sectors. Expert Sudip Bandyopadhyay provides stock-specific insights. Vedanta and NALCO are well-positioned in aluminium. Tata Steel faces uncertainty due to European operations. Sun Pharma and Glenmark are at risk in the pharmaceutical sector due to branded drug exposure.Read More

India’s banking sector demonstrates resilience with steady loan and deposit growth, particularly from private lenders like HDFC Bank. While concerns about margins and global risks persist, the micro-lending cycle has bottomed out, and public sector banks are poised for continued strong performance. Investors are advised to balance opportunities with caution.Read More

Bajaj Alternate Investment Management has secured SEBI approval to launch Portfolio Management Services (PMS), expanding its offerings beyond alternative investment funds. This move targets high-net-worth individuals with customized, research-backed strategies in listed equities. The firm aims to provide disciplined, actively managed solutions for wealth creation amidst evolving market dynamics.Read More

Nykaa’s shares climbed following a robust Q4 FY2026 revenue update. The company anticipates its fastest growth in 12 quarters, driven by a strong fashion segment recovery and steady beauty sales. Full-year net sales are projected to accelerate, with aggressive retail expansion and a growing brand portfolio fueling optimism.Read More

Bitcoin hovered near $69,000, triggering over $146 million in short liquidations as major cryptocurrencies saw gains. Despite a 2% rise in global market cap to $2.36 trillion, analysts note a lack of conviction, with Bitcoin struggling to break past key resistance levels. Transaction fees and exchange balances show significant shifts.Read More